Role of Probiotics in Preventing Carbapenem-Resistant Enterobacteriaceae Colonization in the Intensive Care Unit: Risk Factors and Microbiome Analysis Study
- PMID: 38138114
- PMCID: PMC10745884
- DOI: 10.3390/microorganisms11122970
Role of Probiotics in Preventing Carbapenem-Resistant Enterobacteriaceae Colonization in the Intensive Care Unit: Risk Factors and Microbiome Analysis Study
Abstract
Older patients with multiple comorbidities often necessitate prolonged hospital stays and antibiotic treatment in the intensive care unit (ICU), leading to a rise in multidrug-resistant organisms like carbapenem-resistant Enterobacteriaceae (CRE). This study examined risk factors for carbapenem-resistant Enterobacteriaceae colonization in the ICU and assessed probiotics' preventive role. In this single-center, retrospective study, 9099 ICU patients were tested for stool CRE culture from March 2017 to April 2022. We excluded 136 patients with CRE colonization within one week post-admission and 26 who received probiotics before CRE colonization. Ultimately, 8937 CRE-negative patients were selected. Logistic analysis identified CRE colonization risk factors and evaluated probiotics' influence, including Saccharomyces boulardii or Lactobacillus rhamnosus, used by 474 patients (5.3%) in the ICU. Compared with data on initial admission, 157 patients (1.7%) had newly discovered CRE colonization before discharge. In a multivariate analysis, coronavirus disease 2019, the ICU, tube feeding, antibiotics such as aminoglycoside, extended-spectrum penicillin, stool vancomycin-resistance enterococci colonization, and chronic kidney disease were significantly associated with de novo CRE infection. However, probiotic use was negatively correlated with CRE infection. Managing risk factors and administering probiotics in the ICU may help prevent CRE colonization; large randomized prospective studies are needed.
Keywords: carbapenem-resistant Enterobacteriaceae; prevention; probiotics; risk factor.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Clinical Risk Factors and Microbiological and Intestinal Characteristics of Carbapenemase-Producing Enterobacteriaceae Colonization and Subsequent Infection.Microbiol Spectr. 2022 Dec 21;10(6):e0190621. doi: 10.1128/spectrum.01906-21. Epub 2022 Nov 29. Microbiol Spectr. 2022. PMID: 36445086 Free PMC article.
-
Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department.Emerg Infect Dis. 2020 Jun;26(6):1156-1163. doi: 10.3201/eid2606.190965. Epub 2020 Jun 17. Emerg Infect Dis. 2020. PMID: 32267827 Free PMC article.
-
Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.PLoS One. 2017 Oct 12;12(10):e0186195. doi: 10.1371/journal.pone.0186195. eCollection 2017. PLoS One. 2017. PMID: 29023567 Free PMC article.
-
Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study.J Hosp Infect. 2018 Aug;99(4):481-486. doi: 10.1016/j.jhin.2018.02.018. Epub 2018 Mar 2. J Hosp Infect. 2018. PMID: 29477634
-
Neonates with Maternal Colonization of Carbapenemase-Producing, Carbapenem-Resistant Enterobacteriaceae: A Mini-Review and a Suggested Guide for Preventing Neonatal Infection.Children (Basel). 2021 May 15;8(5):399. doi: 10.3390/children8050399. Children (Basel). 2021. PMID: 34063374 Free PMC article. Review.
Cited by
-
Factors for Treatment Failure After Fecal Microbiota Transplantation in Clostridioides difficile Infection.Microorganisms. 2024 Dec 9;12(12):2539. doi: 10.3390/microorganisms12122539. Microorganisms. 2024. PMID: 39770742 Free PMC article.
-
Safety Assessment and Evaluation of Probiotic Potential of Lactobacillus bulgaricus IDCC 3601 for Human Use.Microorganisms. 2024 Oct 15;12(10):2063. doi: 10.3390/microorganisms12102063. Microorganisms. 2024. PMID: 39458372 Free PMC article.
References
-
- Antibiotic Resistance Threats in the United States, 2019. US Department of Health Human Service; Washington, DC, USA: 2019.
-
- Shin J., Lee J.H., Park S.H., Cha B., Kwon K.S., Kim H., Shin Y.W. Efficacy and Safety of Fecal Microbiota Transplantation for Clearance of Multidrug-Resistant Organisms under Multiple Comorbidities: A Prospective Comparative Trial. Biomedicines. 2022;10:2404. doi: 10.3390/biomedicines10102404. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous